<DOC>
	<DOCNO>NCT00432315</DOCNO>
	<brief_summary>Primary objective : • To assess response rate induction therapy docetaxel/CDDP . Secondary objective : To assess - Resectability induction therapy - Time progression - Overall survival - Safety profile - Quality Life</brief_summary>
	<brief_title>Docetaxel Non Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Histology stag disease Histologically cytologically confirm NSCLC ; histology may include : large cell , squamous cell adenocarcinoma SCLC Resectable unresectable NSCLC stage II ( T12 N1 , T3 N0 ) stage IIIa ( T12 N2 T3 N12 ) stage IIIb ( T13 N3 T4 N03 ) Measurable disease ( bidimensionally unidimensionally accord WHO criterion ) 2 . General condition Karnofsky Status &gt; 70 , age &gt; 70 year → PS &gt; 70 Adequate hematological function ( Hb &gt; 10 g/dl , ANC &gt; 2.0 x 109/L , platelet &gt; 100 x 109/L ) Adequate renal hepatic function : total bilirubin &lt; 1 x upper normal limit ( UNL ) , serum creatinine &lt; 1 x UNL , case limit value creatinine clearance &gt; 60 ml/min , ASAT ALAT &lt; 2.5 x UNL , alkaline phosphatase &lt; 5 x UNL . 1 . Diagnosis Evidence brain metastasis distant metastasis equivalent stage IV disease History prior malignancy , except curatively treat nonmelanoma skin cancer situ carcinoma cervix curatively treat cancer evidence disease least five year Other serious concomitant illness medical condition : Congestive heart failure angina pectoris , except medically control , history myocardial infarction within 1 year study entry , uncontrolled hypertension arrhythmia History significant neurologic psychiatric disorder , include dementia seizure Active infection require i.v . Antibiotics Active ulcer , unstable diabetes mellitus contraindication corticotherapy Hepatic function abnormality : ASAT and/or ALAT &gt; 1.5 x UNL associate alkaline phosphatase &gt; 2.5 x UNL Current peripheral neuropathy WHO grade &gt; 2 2 . Prior concurrent therapy Prior chemotherapy immunotherapy NSCLC , include neoadjuvant adjuvant treatment Prior surgery radiotherapy NSCLC Concurrent treatment experimental drug , unapproved medical procedure anticancer therapy 3 . General condition Pregnant lactate patient Patients ( M/F ) reproductive potential implementing adequate contraceptive measurements The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>